Professor of Radiation Oncology, University Fla College of Medicine
Radiation Oncology
Dr. Nancy P. Mendenhall, MD
|
|
Give Review
Nancy Mendenhall works in the field of Radiation Oncology. She researched medicine at University of Florida College of Medicine. University of Florida College of Medicine is ranked 43/78 in Research/PrimaryCare. She received 5 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Redbook Magazine: Top Breast Cancer Doctors" and "Top Doctors: Florida". Nancy Mendenhall is a published MD. She published 96 publications, including: 'Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.
- Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.
- Rectal Toxicity After Proton Therapy For Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted at the University of Florida Proton Therapy Institute.
- Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy.
- ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma.
- A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of loca...
- Local control in non-metastatic medulloblastoma.
- Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study.
- Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
- Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate Cancer.
- Angiosarcoma after Breast-conserving therapy: Long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART).
- Late toxicity following craniospinal radiation for early-stage medulloblastoma.
- Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute.
- Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal Cancer.
- Hemorrhagic Radiation Cystitis.
- Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate Cancer.
- Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate Cancer is not associated with post-treatment testosterone suppression.
- Proton therapy with concomitant capecitabine for pancreatic and ampullary Cancers is associated with a low incidence of gastrointestinal toxicity.
- Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
- Outcomes in men with large prostates (? 60 cm(3)) treated with definitive proton therapy for prostate Cancer.
- Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate Cancer: Results of two prospective trials.
- Can Proton Therapy Improve the Therapeutic Ratio in Breast Cancer Patients at Risk for Nodal Disease?
- A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas.
- Hip fractures and pain following proton therapy for management of prostate Cancer.
- Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.
- Management of Radiation Proctitis.
- Submandibular Gland-sparing Intensity-modulated Radiotherapy.
- Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy.
- Urethral catheterization facilitates preradiation fiducial marker placement in postProstatectomy patients.
- Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.
- Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate Cancer in men 60 years old and younger.
- Protons Offer Reduced Normal-Tissue Exposure for Patients Receiving Postoperative Radiotherapy for Resected Pancreatic Head Cancer.
- When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?
- Improving the Therapeutic Ratio by Using Proton Therapy in Patients With Stage I or II Seminoma.
- Consolidative Involved-Node Proton Therapy for Stage IA-IIIB Mediastinal Hodgkin Lymphoma: Preliminary Dosimetric Outcomes from a Phase II Study.
- Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-sma...
- Cutaneous Merkel cell carcinoma.
- Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer.
- Proton therapy for prostate Cancer.
- Outcomes of Patients with Non-Hodgkin's Lymphoma Treated with Bexxar With or Without External-Beam Radiotherapy.
- Proton Radiotherapy for Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression.
- Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams.
- Head and neck osteosarcoma.
- Early outcomes from three prospective trials of image-guided proton therapy for prostate Cancer.
- Is radical prostatectomy the 'gold standard' for localized prostate Cancer?
- Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Onc...
- Angiosarcoma after Breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy.
- Dosimetric study of pelvic proton radiotherapy for high-risk prostate Cancer.
- Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated...
- Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck.
- Differences between current and historical Breast cancer axillary lymph node irradiation based on arm position: implications for radiation oncologists.
- Accuracy of Breast cancer axillary lymph node treatment plans based on 2-dimensional imaging: what we should know before interpreting 2-dimensional treatment-planning ...
- Erectile dysfunction after radiotherapy for prostate Cancer.
- The management of adult soft tissue sarcomas.
- Postprostatectomy Radiotherapy for Prostate Cancer.
- The dynamic tumor bed: volumetric changes in the lumpectomy cavity during Breast-conserving therapy.
- Does Surgical Closure Technique Affect Early Mammographic Detection of Tumor Recurrence After Breast-Conserving Therapy?
- Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring.
- Proton therapy for maxillary sinus carcinoma.
- Carcinoma of the nasal cavity and paranasal sinuses.
- Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?
- Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate Cancer therapy.
- Definitive radiotherapy for prostate Cancer.
- ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
- Re-irradiation of head and neck carcinoma.
- Is there a role for routine use of MRI in selection of patients for Breast-conserving cancer therapy?
- Adjuvant radiotherapy for cutaneous melanoma.
- Salivary gland pleomorphic adenoma.
- Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.
- Inverted papilloma of the nasal cavity and paranasal sinuses.
- Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing Breast conserving therapy for early-s...
- Long-term outcomes in Breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.
- Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
- Skin Cancer of the head and neck with perineural invasion.
- Is the Berg axillary lymph node categorization useful in the 3D environment?
- Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation.
- Delayed Breast cellulitis: an evolving complication of Breast conservation.
- Lethal midline granuloma-nasal natural killer/T-cell lymphoma.
- Sinonasal undifferentiated carcinoma.
- Giant cell tumor of bone.
- Minimizing local recurrence after Breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.
- Head and neck mucosal melanoma.
- Merkel cell carcinoma: treatment and outcomes.
- Adult head and neck soft tissue sarcomas.
- Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: a prospective, randomized trial.
- Breast-conserving therapy in patients with bilateral Breast cancer: do today's treatment choices burn bridges for tomorrow?
- A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma.
- Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders.
- Skull base chordoma.
- Inflammatory Breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.
- Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?
- Breast-conserving therapy (BCT) for early-stage Breast cancer.
- Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
- Solitary plasmacytoma of bone and soft tissues.
- Radiation therapy for angiosarcoma.
Schools
University Of Florida College Of Medicine
Shands University Fla
Procedures Preformed
- Radiation Therapy
- Stereotactic Radiosurgery, Spinal
Conditions Treated
- Breast Cancer
- Prostate Cancer
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Redbook Magazine: Top Breast Cancer Doctors
- Top Doctors: Florida
Education
-
University of Florida -
University of Florida College of Medicine
Hospital
-
UF Health Shands Hospital -
UF Health Jacksonville
Drug Facts
| NPI NUMBER | 1407817927 | |
| NPPES Provider LastName | MENDENHALL | |
| NPPES Provider FirstName | NANCY | |
| NPPES Provider ZIPCode | 322063531 | |
| NPPES Provider State | FL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 152.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407817927 |
| Last Name Of The Provider | MENDENHALL |
| First Name Of The Provider | NANCY |
| View All |
Similar Doctors
|
Dr. Daniel J. Indelicato, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. William M. Mendenhall, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John M. Elliott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith L. Lightsey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan M. Chafe, MD |
|
Dr. Lori A. Grow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Kovacs Jr., MD |
|
|
Dr. Laurel A. Warwicke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan L. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tu D. Dan, MD |
|
|
Dr. Julie C. Greenwalt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Herman, MD |
|
|
Dr. Adam L. Holtzman, MD |
|
|
Dr. Lauren M. Kropp, MD |